Article
Phenotype of POLE-mutated endometrial cancer
27 Mar 2019
Abstract excerpt
BACKGROUND AND PURPOSE: Individualized therapy in endometrial cancer, the most common gynaecologic cancer in the developed world, focuses on identifying specific molecular subtypes. Mutations in the exonuclease domain of the DNA polymerase epsilon (POLE) gene define one such subtype, which causes an ultra-mutated tumour phenotype. These tumours may have an improved progression-free survival and may be receptive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
